Preview

Rheumatology Science and Practice

Advanced search

FUNCTIONAL ACTIVITY OF COMPLEMENT CLASSIC WAY ACTIVATION COMPONENTS AND ART1CULAS DAMAGE IN RHEUMATOID ARTRITIS

https://doi.org/10.14412/1995-4484-2000-784

Abstract

A relationship between X - ray joints changes and functional activity of classical pathway complement components in R4 was investigated. 31 patients with the moderate activity ofRA (ARA 1987) have been examined. Disease duration was 4,5lyear±3,84 (SD). X-ray stage was estimated by Steinbrocker (I-II-III-IV). II patients were in II stage, 8 in III stage, 12 in IV-stage. Concentration of C3 and C4 components have been evaluated by radial immunodiffuision, functional activity of complement components (Clq. C1-C5) - using a microhemolilical systems. High correlation values between functional activity C1-C4 complement components and X-ray stage of disease were obtained (Spearman correlation: 0,38<R<0,7 [10 5<p<0,03]). Thereby high FA of classical pathway complement components is associated with severe joints destruction. Correlation ofC3, C4 concentration was not significant. This fact can be resulting from the phenomenon that complement classical pathway take part in joints destruction in RA. The feature of relationship can be ascribed to both primary high FA of complement classical pathway in patients with se\'ere joints destruction and local consumption of complement at early stage ofjoints destruction.

References

1. <div><p>Козлов Л.В., Агеев В.П., Сизой М.Н. и др. Клиническая медицина - 1991, 3, 60-63.</p><p>Насонов Е.Л. Противовоспалительная терапия ревматических болезней. М-СИТИ, Москва, 1996, с 345.</p><p>Ревматические болезни. Под редакцией Насоновой В.А., Бунчука Н.В. М. “Медицина” - 1997, с. 260-261.</p><p>Asghar S. Pharmacological manipulation of the complement system in human diseases. Amsterdam, Academisch Medisch Centrum, Universiti of Amsterdam. Internet-Address: Therapeutic uses of high molecular weight inhibitors of complement. Received 12/08/96; On-line 03/01/96.</p><p>Geissler N., Kemper A., Krapf E. Demonstration and differentiation of circulating immune complexes in chronic inflammatory rheumatic diseases using a semiautomated PEG-precipita- tion laser nephelometer test. Z. Rheumatol, 1985, 44(2), 57-63.</p><p>Hebert L.A. The erytrocyte immune-complex glomerulonerphritis connection in man. Kidney International, 1987, 31, 877-85.</p><p>Konttinen Y.T., Ceponis A., Men S., Vuorikos- ki A. Complement in acute and chronic arthriti- des: assessment of СЗс, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis 1996, 55, 888-894.</p><p>Pai S., Pai L., Birkenfeld R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand. J. Rheumatol 1998, 27(4), 252-6.</p><p>Schroder F., Zuener R.A., Schroder J.O., Euler H. H. Komplementproteinr C3, C3d und C4 im- ter der Behandlung mit mtravenosen Immuno- globulinen bei Dermato - und Polimiositis.</p><p>Tomooka K. Serum complement levels in patients with rheumatoid arthritis and vasculitis. Fukuoka Igaku Zasshi. 1989,10, 80(10): 456-66.</p><p>Vaith P., Prasauskas V., Potempa L.A., Peter H. H. Complement activation by C-reactive protein on the Hep-2 cell substrate. Int. Arch. Allergy. Immunol, 1996, 111, 407-417.</p></div><br />


Review

For citations:


Goryachev D.L., Lebedeva T.V. FUNCTIONAL ACTIVITY OF COMPLEMENT CLASSIC WAY ACTIVATION COMPONENTS AND ART1CULAS DAMAGE IN RHEUMATOID ARTRITIS. Rheumatology Science and Practice. 2000;38(1):31-34. (In Russ.) https://doi.org/10.14412/1995-4484-2000-784

Views: 847


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)